Related Experiment Video
Updated: Jul 14, 2026
07:39
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Suction due to left ventricular assist: implications for device control and management
Koen Reesink1, André Dekker, Theo Van der Nagel
1Department of Biophysics, Cardiovascular Research Institute Maastricht/Maastricht University, The Netherlands.
Artificial Organs
|June 23, 2007
Summary
Left ventricular assist device (LVAD) suction can cause significant hemodynamic depression. Pump interventions can detect and prevent this suction-induced collapse, improving patient outcomes.
Area of Science:
- Cardiovascular Physiology
- Medical Device Engineering
Background:
- Left ventricular assist device (LVAD) overpumping is linked to adverse effects like hemolysis and thrombus formation.
- The impact of LVAD suction on pulmonary circulation is not well understood.
Purpose of the Study:
- To investigate the effects of LVAD suction on pulmonary circulatory function.
- To explore methods for detecting and mitigating suction-induced hemodynamic depression.
Main Methods:
- LVAD suction was induced in experimental animals (sheep) via pulmonary artery occlusion and overpumping.
- A computer model simulated pulmonary artery occlusion and varying hemodynamic conditions.
- Measurements included pressures, flows, and hemodynamic collapse duration.
Main Results:
- LVAD suction, induced by pulmonary artery occlusion, caused significant drops in aortic pressure and LVAD flow.
- Predisposing factors like increased pulmonary vascular resistance or RV dysfunction exacerbated suction-induced collapse.
- Increasing LVAD speed induced collapse, while temporary device shutdown reversed it.
Conclusions:
- Rotary LVAD suction creates unfavorable conditions for effective cardiac unloading.
- Pump interventions are a promising strategy for detecting LVAD suction and preventing hemodynamic depression.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...